Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Accured Expenses (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Change in Accured Expenses for 17 consecutive years, with -$6.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 75.64% to -$6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$27.5 million, a 32.93% increase, with the full-year FY2025 number at -$27.5 million, up 32.93% from a year prior.
  • Change in Accured Expenses was -$6.7 million for Q4 2025 at Myriad Genetics, down from $8.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $71.9 million in Q2 2023 to a low of -$59.4 million in Q4 2023.
  • A 5-year average of -$3.1 million and a median of -$6.0 million in 2023 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: plummeted 7000.0% in 2021, then surged 4340.0% in 2023.
  • Myriad Genetics' Change in Accured Expenses stood at -$14.2 million in 2021, then soared by 80.28% to -$2.8 million in 2022, then tumbled by 2021.43% to -$59.4 million in 2023, then skyrocketed by 53.7% to -$27.5 million in 2024, then skyrocketed by 75.64% to -$6.7 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Change in Accured Expenses are -$6.7 million (Q4 2025), $8.4 million (Q3 2025), and -$16.8 million (Q2 2025).